Pearl Therapeutics' Bronchodilator Combination Therapeutic for COPD to Be Presented at the American Thoracic Society Annual Meeting

-- Four Presentations to Feature Clinical Results and Drug
Delivery Characteristics of Pearl's Combination Bronchodilator,
PT003, and its Components --
REDWOOD CITY, Calif., May 5 /PRNewswire/ -- Pearl Therapeutics
Inc., a company developing...

More on Wikipedia

    More on Sciencestage.com

      More on Answers.com

        More on Pubmed

          More on answers.yahoo.com

            News